Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Biomaterials. 2017 Oct 21;152:63–76. doi: 10.1016/j.biomaterials.2017.10.036

Figure 2.

Figure 2

Effect of Abraxane on mice bearing MDA-MB-435 breast tumors. (A) Growth curves of MDA-MB-435 tumors treated with 5 daily doses of Abraxane or untreated control. Day 0 indicates the day that the first of the 5 daily doses was administered. (mean ± SE, n = 8/group). (B) Growth curves of MDA-MB-435 tumors treated with 1 dose of Abraxane or untreated control. Day 0 indicates the day that Abraxane was administered. (mean ± SE, n = 5/group). (C) Staining for the apoptosis marker TUNEL (green) and the activated macrophage marker CD169 (red) in untreated and Abraxane-treated MDA-MB-435 tumors (DAPI nuclear stain, blue) (original magnification ×100; scale bar, 100 μm).